Common Contracts
3 similar Securities Purchase Agreement contracts by Hemispherx Biopharma Inc, NovaBay Pharmaceuticals, Inc.
Se c u r it ie s Pu r c h a s e Ag r e e m e n tSecurities Purchase Agreement • November 26th, 2023 • Utah
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of June 20, 2019, is entered into by and between THC THERAPEUTICS, INC., a Nevada corporation (“Company”), and ILIAD RESEARCH AND TRADING, L.P., a Utah limited partnership, its successors and/or assigns (“Investor”).
Securities Purchase AgreementSecurities Purchase Agreement • March 28th, 2019 • NovaBay Pharmaceuticals, Inc. • Pharmaceutical preparations • Utah
This Securities Purchase Agreement (this “Agreement”), dated as of March 26, 2019, is entered into by and between NovaBay Pharmaceuticals, Inc., a Delaware corporation (“Company”), and Iliad Research and Trading, L.P., a Utah limited partnership, its successors and/or assigns (“Investor”).
Securities Purchase AgreementSecurities Purchase Agreement • October 4th, 2018 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances) • Utah
This Securities Purchase Agreement (this “Agreement”), dated as of September 28, 2018, is entered into by and between Hemispherx Biopharma, Inc., a Delaware corporation (“Company”), and Iliad Research and Trading, L.P., a Utah limited partnership, its successors and/or assigns (“Investor”).
